Oramed Pharmaceuticals Inc. (ORMP) — 10-Q Filings

10-Q Filings (6)

• Oramed Swings to Profit on Soaring Financial Income, Strategic Investments — Nov 13, 2025 Risk: high
  ORAMED PHARMACEUTICALS INC. reported a significant turnaround for the nine months ended September 30, 2025, achieving a net income of $54.007 million, a substan
• Oramed's Q2 Net Income Jumps Amid JV Delays, Cash Drains — Aug 14, 2025 Risk: high
  ORAMED PHARMACEUTICALS INC. reported a net income of $13,260 thousand for the three months ended June 30, 2025, a significant increase from $9,204 thousand in t
• Oramed Pharmaceuticals Files Q1 2025 10-Q — May 15, 2025 Risk: low
  Oramed Pharmaceuticals Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is based in New
• Oramed Pharmaceuticals Files Q3 2024 10-Q — Nov 7, 2024 Risk: low
  Oramed Pharmaceuticals Inc. filed its quarterly report for the period ending September 30, 2024. The company, incorporated in Delaware, is based in New York and
• Oramed Pharmaceuticals Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
  Oramed Pharmaceuticals Inc. filed its quarterly report for the period ended June 30, 2024. The company, incorporated in Delaware, reported its financial status
• Oramed Pharmaceuticals Inc. Files 10-Q for Period Ended March 31, 2024 — May 9, 2024 Risk: low
  ORAMED PHARMACEUTICALS INC. (ORMP) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Oramed Pharmaceuticals Inc. filed a 10-Q quarterly report for th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX